🌐 Website Architecture & Navigation
HTML Sitemap Directory
Explore all 43 indexed pages, commercial API products, finished formulations, specialty intermediates, regulatory dossiers, and industry articles across the PEC Pharma ecosystem.
🔍
🏢
Company & Information
7 URLs
Home PageOverview, hero highlights, client network & certifications
CoreAbout PEC PharmaCorporate story, leadership, R&D and Saykha plant
AboutQuality & GMP ComplianceICH Q3A/B standards, QC analytical lab & DMFs
QualityTherapeutic AreasCNS, Respiratory, Cardiovascular, Urology, ENT
AreasGlobal PresenceExporting to LATAM, CIS, SEA, South Asia & Africa
GlobalCareers at PEC PharmaOpen roles in R&D, QA, QC and Regulatory Affairs
HiringContact UsEnquiries, sample requests, quotes & facility addresses
Contact🧪
Product Portfolios & Services
6 URLs
Product Ecosystem OverviewFull range of APIs, formulations, intermediates & CDMO
OverviewComplex Active Pharmaceutical IngredientsCommercial APIs and scale-up molecules with DMF
APIsFinished FormulationsTablets, capsules, oral liquids & injectables (50+ dossiers)
FormulationsSpecialty Intermediates27+ chemical intermediates with documented CAS numbers
IntermediatesCRDMO & CDMO ServicesCryogenic reactions (-80°C), kilo lab & commercial scaling
ServicesPharmaceutical ImpuritiesReference standards, nitroso impurities & analytical COA/NMR
Standards💊
Commercial Active Pharmaceutical Ingredients (APIs)
17 URLs
Acamprosate Calcium APICAS 77337-73-6 • Alcohol Deterrents
CommercialXylometazoline HCL APICAS 1218-35-5 • Topical Nasopharyngeal
CommercialOxymetazoline HCL APICAS 2315-02-8 • Topical Nasopharyngeal
CommercialBupropion HCL APICAS 31677-93-7 • Antidepressant
CommercialLacosamide APICAS 175481-36-4 • Antiepileptic
CommercialSilodosin APICAS 160970-54-7 • Alpha-Blocker (BPH)
CommercialMirtazapine APICAS 85650-52-8 • Antidepressant
Under Scale-Up / R&DPramipexole Di-HCL APICAS 191217-81-9 • Dopamine Agonists
Under Scale-Up / R&DLinezolid APICAS 165800-03-3 • Antibiotic
Under Scale-Up / R&DDimethyl Fumarate APICAS 624-49-7 • Immunomodulators
Under Scale-Up / R&DBaclofen APICAS 1134-47-0 • Antispasmodic
Under Scale-Up / R&DBisacodyl APICAS 603-50-9 • Stimulant Laxative
Under Scale-Up / R&DSildenafil Citrate APICAS 171599-83-0 • Erectile Dysfunction
Under Scale-Up / R&DTopiramate APICAS 97240-79-4 • Anticonvulsants
Under Scale-Up / R&DOmeprazole APICAS 73590-58-6 • Gastrointestinal Agent
Under Scale-Up / R&DLansoprazole APICAS 103577-45-3 • Gastrointestinal Agent
Under Scale-Up / R&DCilostazol APICAS 73963-72-1 • Anticoagulant
Under Scale-Up / R&D📰
Articles & Industry Insights
7 URLs
All Blog Articles & NewsTechnical updates, GMP guidelines & regulatory news
NewsAdvancements in Complex API ManufacturingContinuous flow chemistry breakthroughs in API synthesis
ArticleGMP Compliance: Meeting Global StandardsInside the GIDC Saykha facility quality control protocols
ArticleExpanding Our Reach in LATAM MarketsDossier filings across Bolivia, Peru, Guatemala and LATAM
ArticleOvercoming Challenges in Stereoselective SynthesisChiral separation techniques for enantiomeric purity
ArticleRegulatory Readiness for European MarketsPreparing for EMA audits and upcoming submissions
ArticleThe Role of Reference Standards in API Impurity ProfilingMitigating nitroso risks under ICH Q3A/Q3B guidelines
Article📄
Regulatory Documents & Certificates
4 URLs
🤖
Search Engine Crawlers & System Files
2 URLs